Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 1
2009 1
2017 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Coexistence of Pancytopenia and Myositis After Developing COVID-19.
Okayasu T, Ohta R, Igarashi M, Kurita Y, Hayakawa M, Sano C. Okayasu T, et al. Among authors: hayakawa m. Cureus. 2022 Jul 18;14(7):e26978. doi: 10.7759/cureus.26978. eCollection 2022 Jul. Cureus. 2022. PMID: 35989844 Free PMC article.
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor.
Honma D, Kanno O, Watanabe J, Kinoshita J, Hirasawa M, Nosaka E, Shiroishi M, Takizawa T, Yasumatsu I, Horiuchi T, Nakao A, Suzuki K, Yamasaki T, Nakajima K, Hayakawa M, Yamazaki T, Yadav AS, Adachi N. Honma D, et al. Among authors: hayakawa m. Cancer Sci. 2017 Oct;108(10):2069-2078. doi: 10.1111/cas.13326. Epub 2017 Aug 8. Cancer Sci. 2017. PMID: 28741798 Free PMC article.
Cinnamyl derivatives: synthesis and factor Xa (FXa) inhibitory activities.
Noguchi T, Tanaka N, Nishimata T, Goto R, Hayakawa M, Sugidachi A, Ogawa T, Asai F, Fujimoto K. Noguchi T, et al. Among authors: hayakawa m. Chem Pharm Bull (Tokyo). 2008 Jun;56(6):758-70. doi: 10.1248/cpb.56.758. Chem Pharm Bull (Tokyo). 2008. PMID: 18520077 Free article.
Indoline derivatives I: synthesis and factor Xa (FXa) inhibitory activities.
Noguchi T, Tanaka N, Nishimata T, Goto R, Hayakawa M, Sugidachi A, Ogawa T, Asai F, Matsui Y, Fujimoto K. Noguchi T, et al. Among authors: hayakawa m. Chem Pharm Bull (Tokyo). 2006 Feb;54(2):163-74. doi: 10.1248/cpb.54.163. Chem Pharm Bull (Tokyo). 2006. PMID: 16462058 Free article.
Indoline derivatives II: synthesis and factor Xa (FXa) inhibitory activities.
Noguchi T, Tanaka N, Nishimata T, Goto R, Hayakawa M, Sugidachi A, Ogawa T, Asai F, Ozeki T, Fujimoto K. Noguchi T, et al. Among authors: hayakawa m. Chem Pharm Bull (Tokyo). 2007 Mar;55(3):393-402. doi: 10.1248/cpb.55.393. Chem Pharm Bull (Tokyo). 2007. PMID: 17329879 Free article.